Publications by authors named "Reid P Bissonnette"

Claim this Profile
T
The epigenetic immunomodulator, HBI-8000, enhances the response and reverses resistance to checkpoint inhibitors.
Reid P Bissonnette, Rosemary M Cesario, Bob Goodenow, Farbod Shojaei, Mireille Gillings

BMC Cancer· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of apoptosis by HBI-8000 in adult T-cell leukemia/lymphoma is associated with activation of Bim and NLRP3.
Hiroo Hasegawa, Reid P Bissonnette, Mireille Gillings, Daisuke Sasaki, Hiroaki Taniguchi

Cancer Sci· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The combination of tamoxifen and the rexinoid LG100268 prevents ER-positive and ER-negative mammary tumors in p53-null mammary gland mice.
Abhijit Mazumdar, Daniel Medina, Francis S Kittrell, Yun Zhang, Jamal L Hill, Reid P Bissonnette

Cancer Prev Res (Phila)· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer-preventive rexinoid modulates neutral lipid contents of mammary epithelial cells through a peroxisome proliferator-activated receptor γ-dependent mechanism.
Iván P Uray, Jennifer M Rodenberg, Reid P Bissonnette, Powel H Brown, Michael A Mancini

Mol Pharmacol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The rexinoid bexarotene represses cyclin D1 transcription by inducing the DEC2 transcriptional repressor.
Yuxin Li, Qiang Shen, Hee-Tae Kim, Reid P Bissonnette, William W Lamph

Breast Cancer Res Treat· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of modulated genes by three classes of chemopreventive agents at preneoplastic stages in a p53-null mouse mammary tumor model.
Martín C Abba, Yuhui Hu, Carla C Levy, Sally Gaddis, Frances S Kittrell, Reid P Bissonnette

Cancer Prev Res (Phila)· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rexinoid-induced expression of IGFBP-6 requires RARbeta-dependent permissive cooperation of retinoid receptors and AP-1.
Iván P Uray, Qiang Shen, Hye-Sook Seo, HeeTae Kim, William W Lamph, Reid P Bissonnette

J Biol Chem· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptomic signature of bexarotene (rexinoid LGD1069) on mammary gland from three transgenic mouse mammary cancer models.
Martin C Abba, Yuhui Hu, Carla C Levy, Sally Gaddis, Frances S Kittrell, Reid P Bissonnette

BMC Med Genomics· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
G0S2 is an all-trans-retinoic acid target gene.
Sutisak Kitareewan, Steven Blumen, David Sekula, Reid P Bissonnette, William W Lamph

Int J Oncol· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination chemoprevention of HER2/neu-induced breast cancer using a cyclooxygenase-2 inhibitor and a retinoid X receptor-selective retinoid.
Powel H Brown, Kotha Subbaramaiah, Amoi P Salmon, Rebecca Baker, Robert A Newman, Reid P Bissonnette

Cancer Prev Res (Phila)· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo and microarray analysis of rexinoid-responsive anaplastic thyroid carcinoma.
Joshua P Klopper, Andrew Berenz, William R Hays, Vibha Sharma, Umarani Pugazhenthi, Reid P Bissonnette

Clin Cancer Res· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Rexinoid LG100268 prevents the development of preinvasive and invasive estrogen receptor negative tumors in MMTV-erbB2 mice.
Yuxin Li, Yun Zhang, Jamal Hill, Qiang Shen, Hee-Tae Kim, Reid P Bissonnette

Clin Cancer Res· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and characterization of nonsteroidal glucocorticoid receptor modulators for multiple myeloma.
Andrew R Hudson, Steven L Roach, Robert I Higuchi, Dean P Phillips, Reid P Bissonnette

J Med Chem· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differentiation and growth inhibition mediated via the RXR:PPARgamma heterodimer in colon cancer.
Rosemary M Cesario, Jessica Stone, Wan-Ching Yen, Reid P Bissonnette, William W Lamph

Cancer Lett· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Receptor-selective retinoids inhibit the growth of normal and malignant breast cells by inducing G1 cell cycle blockade.
Kendall Wu, Elizabeth DuPré, Heetae Kim, Caesar K Tin-U, Reid P Bissonnette

Breast Cancer Res Treat· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The retinoid X receptor agonist bexarotene (Targretin) synergistically enhances the growth inhibitory activity of cytotoxic drugs in non-small cell lung cancer cells.
Thomas W Hermann, Wan-Ching Yen, Patricia Tooker, Bingqi Fan, Karen Roegner, Reid P Bissonnette

Lung Cancer· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nuclear receptor activation and interaction with morphine.
Walter Royal, Michelle Leander, Yuqing E Chen, Eugene O Major, Reid P Bissonnette

J Neuroimmunol· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A selective retinoid X receptor agonist bexarotene (Targretin) prevents and overcomes acquired paclitaxel (Taxol) resistance in human non-small cell lung cancer.
Wan-Ching Yen, Manny R Corpuz, Rene Y Prudente, Tracy A Cooke, Reid P Bissonnette

Clin Cancer Res· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RXR-induced TNF-alpha suppression is reversed by morphine in activated U937 cells.
Liping Mou, Pamela Lankford-Turner, Michelle V Leander, Reid P Bissonnette, Robert M Donahoe

J Neuroimmunol· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis